$110.48
▼ -0.1% Today
as of Jul 22, 10:02 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 25
▼ 0
Why Did CVS, URGN, CCK Stocks Hit 52-Week Highs Today?
CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing
Pet medications now available at CVS Pharmacy®
Overview
52-week range
$58
$98
100% of range
Avg surprise (last 3)
+23.7%
Avg reaction (last 2)
+5.9%
100% positive
Latest IV / EM
35%
EM ±2.5% · $110 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $2.57 | $2.21 | +16.3% | +14.2% | +7.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-3.13 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $1.81 | $1.47 | +23.1% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $2.25 | $1.71 | +31.6% | — | +4.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.07 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.41 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.88 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.75 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.48 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | BMO | $1.87 | $1.81 | +3.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $100.43B | — | $102.87B | $98.92B | $94.59B | — | $95.43B | $91.23B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $4.68B | — | $-3.21B | $2.38B | $3.37B | — | $832M | $3.04B |
| Net income | $2.94B | — | $-3.98B | $1.02B | $1.78B | — | $87M | $1.77B |
| EPS (diluted) | $2.30 | — | $-3.13 | $0.80 | $1.41 | — | $0.07 | $1.41 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B |
| Inventory | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B |
| Total current assets | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B |
| Total assets | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B |
| Total equity | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B |